From Weeks to Hours: Why Batch Release Is the Next Frontier of Life Sciences Digitalisation and How SAP’s Automated Batch Release Hub Gets You There

Introduction

Every batch of medicine that reaches a patient passes through one final gate: the release decision. A Qualified Person (QP) or QA lead reviews the evidence, batch records, lab results, deviations, certificates, regulatory approvals and signs a legally binding statement that the product is fit for market. That decision is the most consequential moment in pharmaceutical manufacturing. It is also, in most organisations, the least digitalised. Production has been automated. Labs have been instrumented. Serialisation has been mandated and delivered. Yet the release step itself still runs on portals, spreadsheets and the institutional memory of overloaded QPs.

SAP Batch Release Hub (BRH) for Life Sciences Digitalisation was built to close that gap – bringing structure, automation and AI-assisted decision support to the one step that still runs on spreadsheets and institutional memory. This article explains why batch release has become the bottleneck, how BRH reframes the problem, and where AI is taking the release process next.

The Industry Challenge: Release Has Not Kept Pace with Production

Ask a QP what a release actually involves and the answer is rarely “one decision”. It is closer to a scavenger hunt across five to ten systems: the ERP for batch and inspection-lot data, the MES for execution records, the LIMS for analytical results, the QMS for deviations and change control, the DMS for the inspection plan and SOPs, the RIMS for market authorisations, the track-and-trace system for serialisation status, plus emails, PDFs and paper for everything that falls between them.

The process typically looks like this: locate the right inspection plan in the ERP or DMS; log into each source system in turn to check the individual release criteria; record the outcome on a paper or PDF form under good documentation practice; log into the ERP to post the usage decision and stock movement; scan and file the completed record so it can be retrieved during the next audit.

The consequences are well documented across the industry: labour-intensive, repetitive work for highly qualified people; error-prone manual transcription that creates compliance risk; long qualification periods for new hires because the process lives in people’s heads rather than in a system; release lead times measured in days or weeks, which inflate safety stock and inventory carrying costs; and no scalability for the smaller, more frequent batches that cell and gene therapies, personalised medicine and clinical supply demand.

The paradox is stark. Pharma 4.0 initiatives have cut manufacturing cycle times substantially — yet a sterile injectable batch whose MES record closes in 24 hours can still wait 20 days for release while lab results consolidate, deviations close and cross-system reconciliation happens by hand. Manufacturing got faster. Release did not.

Market Trends Reshaping Batch Release

Several forces are converging to make this status quo untenable.

Regulators are rewriting the digital rulebook. In July 2025 the European Commission published drafts of a revised EU GMP Annex 11 (Computerised Systems), a revised Chapter 4 (Documentation) and an entirely new Annex 22 on Artificial Intelligence. Annex 11 grows from five pages to nineteen, with a sharp new emphasis on identity and access management, audit trails, electronic signatures and data integrity. Annex 22 sets out, for the first time, how AI models may be used in critical GMP applications — intended use, acceptance criteria, independent test data, explainability and confidence thresholds. The message is clear: digital, auditable, well-governed systems are no longer a nice-to-have.

Annex 16 has moved supply-chain transparency onto the QP’s desk. QP certification now presumes visibility of the entire authorised supply chain for the product – every site, every step, every market. Jurisdiction control and supply chain maps are becoming a release-time requirement, not a regulatory-affairs afterthought.

Serialisation is mature, and its data is finally usable. A decade of DSCSA, EU FMD and national track-and-trace mandates means most manufacturers now hold rich, structured serialisation data in systems such as SAP ATTP. The next step is obvious: use that data as a release check rather than leaving it in a silo.

Portfolios are fragmenting. Advanced therapies, personalised medicines and clinical trial supply mean more products, smaller batches and far more release events per unit of revenue. A release process designed for large commercial lots simply cannot absorb this volume.

The ERP backbone is moving to the cloud. S/4HANA migrations and SAP’s Cloud ERP strategy are pushing life sciences companies to reconsider which quality processes belong in the core and which belong in purpose-built industry applications on SAP Business Technology Platform (BTP).

Talent is scarce. Experienced QPs are hard to find and expensive to train. Organisations cannot keep solving throughput problems by adding headcount.

The Shift: From Data Collection to Decision Support

The real shift is conceptual. Batch release has historically been treated as a documentation problem: gather the evidence, file it correctly, sign it. The leading organisations now treat it as a decision problem: what does the QP actually need to know, and how quickly can the system put it in front of them with confidence that it is complete and correct?

That reframing changes everything about how the process should be designed:

  • Evidence comes to the decision-maker. Data from ERP, MES, LIMS, QMS, DMS, RIMS and serialisation systems is pulled into a single release cockpit mapped to a standard set of release checks, not scattered across logins.
  • Deterministic checks run automatically. Certificate of analysis present? Component batches approved? Deviation closed? Market authorisation valid? These are rules, not judgements. Business rules evaluate them the moment data arrives so by the time a human looks, the green checks are already green.
  • Humans focus on genuine judgement. Review by exception means the QP spends their time on the two checks that are amber, not the eighteen that are fine.
  • The decision flows back automatically. A release is only useful if it becomes a usage decision, a stock posting and a certificate in the ERP without re-keying.

 

This is precisely the model SAP Batch Release Hub implements. Co-innovated with leading pharmaceutical companies and delivered as a SaaS application on SAP BTP, BRH is the central release platform, tightly integrated with the S/4HANA backbone and open via OData APIs to non-SAP systems.

BRH’s release check portfolio covers the full spectrum of what a QP verifies, with each check evaluated by configurable business rules so a policy change is a rule update, not a development project:

  • Batch record review and certificate checks
  • Quality control data and deviation / change control
  • Component and batch genealogy (down to sub-component level)
  • Regulatory data, jurisdiction control and market authorisations
  • Serialisation data and temperature / transport records
  • Artwork, safety labels and annual product quality review
  • Clinical trial regulatory and technical checks
  • Fully custom release checks for organisation-specific requirements

 

BRH covers every release scenario in the real supply chain across multiple business entities and QA departments, with role-based worklists, GxP-grade e-signature, full audit logs, and data freezing after release:

  • Incoming goods release
  • Bulk and semi-finished release
  • Finished goods and CMO release
  • Market release and distribution release

 

Once the QP signs, the release decision is sent back to S/4HANA automatically, updating batch characteristics, posting inspection-lot stock and generating the certificate.

The outcome is not just a faster process but a fundamentally more reliable one: standardised across the organisation, transparent to auditors, and scalable to batch sizes that manual release could never economically handle.

AI and Technology Transformation: The Batch Release Assistant

Automating deterministic checks solves most of the volume. It does not solve the part of release that is buried in unstructured documents the 200-page batch record, the CMO’s release dossier, the scanned COA, the paper checklist that a site has used for fifteen years.

This is where generative AI is now entering the release process, and where SAP has been notably careful to keep the human in the loop.

AI-assisted custom release checks. SAP Business AI in BRH analyses the documents attached to a custom release check and proposes results for each check item directly in the QP’s interface, with references back to the source. The QP reviews, verifies and signs — the role of final decision-maker never moves. SAP’s own estimate, based on customer feedback, is that a custom release check that took a QP around two hours can be completed in roughly forty-five minutes, an improvement of up to sixty percent in QP productivity. Just as importantly, it turns paper checklists into structured digital checks, using AI as the bridge to data sources that were never going to be integrated by API.

Fully automated release for low-risk scenarios. For release types where every check is deterministic and the risk profile allows it, BRH now supports configurable automated outcomes — a business-rules-driven release decision without human intervention and, where appropriate, without e-signature. This is the “zero-time” release that makes high-volume, small-batch models viable.

Serialisation as a release check. The evolving integration between BRH and SAP ATTP brings serialisation and aggregation status into the release cockpit, so that a batch cannot be released to a market whose track-and-trace requirements it does not yet satisfy.

Towards an agentic Batch Release Assistant. SAP’s stated direction is to evolve BRH into an AI-first release platform — with specialised agents for SOP interpretation, compliance checking, and release automation working alongside the QP. The design principle is scalable autonomy: the organisation decides, scenario by scenario, how much the system may do on its own.

Future Outlook

Looking towards the end of the decade, three developments seem likely.

  • Release becomes continuous rather than terminal. Instead of a retrospective verification at the end of the batch, release readiness will be assessed in near real time as data arrives — a batch will carry a live “distance to release” throughout its lifecycle, and quality teams will intervene when a check turns amber, not when the batch is already sitting in quarantine.
  • The QP becomes an exception manager and risk owner. As deterministic checks and AI-assisted document review absorb the routine workload, the QP’s role concentrates on judgement, risk assessment and the governance of the automation itself — deciding what the system may release autonomously and validating that it does so correctly. That is a more valuable use of a scarce skill, and arguably a more defensible one under Annex 16.
  • Release, serialisation and supply chain converge. Jurisdiction control, supply chain maps, serialisation status and market authorisation data will be evaluated together at the moment of release, closing the loop between what a company is authorised to sell, what it has actually made, and where it is allowed to ship it. The companies that treat batch release, track-and-trace and regulatory data as one connected process will have a structural advantage in speed to market and inspection readiness.

 

The direction of travel is clear. What differs between organisations is how quickly, and how safely, they get there.

How Novatio Can Help

Novatio specialises in SAP track & trace, serialisation and regulated supply chain for life sciences — with batch release at the intersection of everything we do: the S/4HANA quality backbone, serialisation data in SAP ATTP, and industry cloud applications on SAP BTP.

  • Assessment and business case. We map your current release process, quantify cycle time and inventory impact, and build the value case, identifying which release types are candidates for automation and which need AI-assisted or manual checks.
  • Solution design and integration architecture. We design the end-to-end integration between BRH and your landscape – S/4HANA, LIMS, MES, QMS, DMS and SAP ATTP – bringing specific experience in the master-data and configuration decisions that determine whether a rollout is smooth or painful.
  • Business rules and release check configuration. We translate your SOPs into configurable business rules on SAP BTP extending SAP’s preconfigured rule projects without touching standard content, so your logic survives SAP’s twice-yearly releases.
  • GxP validation and compliance. We deliver the validation documentation, e-signature setup, role and access design, and audit-trail evidence required under Annex 11, and prepare your AI governance approach ahead of Annex 22.
  • AI adoption and global rollout. We introduce AI-assisted release checks and automated outcomes in a controlled, risk-based sequence then scale from pilot site to multi-entity, multi-jurisdiction deployment with the change management and hypercare to make it stick.

 

Get in touch with Novatio to start the conversation.

Novatio — SAP Track & Trace, Serialisation and Batch Release specialists for Life Sciences.

About the Author

Ankit-Singla-2

Share this article

Read More Articles

Supply Chain Traceability: The Enterprise Architecture Behind SAP Corporate Serialization

Read More

The 40% Problem: Why Agentic AI Projects Fail, and How to Be in the Other 60%

Read More

The Autonomous Enterprise: Why the Next 18 Months Will Separate AI Leaders from AI Followers

Read More
Hi, I'm Nexi, how may I help you?
Chat Icon
Chat Logo Nexi

Empower your contact center with AI-powered customer service and intelligent workforce automation to reduce call volumes, improve service quality, and drive better customer satisfaction with real-time call insights and sentiment analysis.

Our fully managed AI lifecycle services guarantee that your Conversational AI for business solution scales with evolving business needs while ensuring security, compliance, and operational efficiency.
We continuously monitor and optimize AI performance through conversational analytics, A/B testing, and model retraining to ensure high accuracy, efficiency, and long-term business success.
Our AI-powered IVR automation and intelligent call deflection solutions seamlessly integrate with your telephony infrastructure, including SIP systems and cloud contact centers, optimizing customer interactions.
From the full-scale development and deployment of Conversational AI technology to seamless integration with your existing infrastructure, we ensure smooth and scalable solutions that enhance AI-powered customer service and automate workflows efficiently.
We guide your AI adoption journey with assessments, strategic roadmaps, and conversational AI design expertise, focusing on real business outcomes. Our solutions include use case identification and business-driven ROI modeling for impactful AI for customer engagement implementations.
Custom-built voice AI assistants, chatbots, and AI-powered IVR systems are designed to meet your unique business needs. Our solutions optimize customer interactions and enhance human productivity with advanced AI for customer engagement capabilities.
We tailor AI solutions for marketing and industry-specific needs with deep domain knowledge. Our vertical solutions automate processes, enhance decision-making, and deliver tangible results, turning Generative AI models into competitive advantage within your unique operational context.
Accelerate innovation with our fully managed Generative AI platform solutions. From AI content generation to seamless integration, we handle model selection, fine-tuning, and deployment, delivering secure, production-ready solutions that empower your enterprise with advanced Generative AI models.
We guide you through the maze of hype and promise of Generative AI for enterprise. Our team identifies high-impact use cases, aligns them with your business goals, and develops a clear roadmap. From Custom AI models for business to responsible AI governance, we ensure your journey is strategic, ethical, and scalable.
Empower your contact center with AI-powered customer service and intelligent workforce automation to reduce call volumes, improve service quality, and drive better customer satisfaction with real-time call insights and sentiment analysis.
Our fully managed AI lifecycle services guarantee that your Conversational AI for business solution scales with evolving business needs while ensuring security, compliance, and operational efficiency.
We continuously monitor and optimize AI performance through conversational analytics, A/B testing, and model retraining to ensure high accuracy, efficiency, and long-term business success.
Real-time view of test results, batch record reviews, deviation status, shelf-life checks, and batch genealogy, consolidated for confident decision-making.
Facilitate seamless exchange and execution of subcontracting purchase orders for external clinical finished goods (CFG) production, improving collaboration with research and manufacturing partners.
Achieve detailed visibility down to site and kit ID levels. Support picking, packing, repackaging, and integrating third-party logistics through GS1-compliant interfaces.
Manage medication lists for both open and blind serialized trials, including batch allocation and expiry date tracking. Support internal packaging, external labeling, and efficient shelf-life management aligned with GxP standards.
Perform precise demand calculations and simulate multiple scenarios based on projected or actual subject enrollment and visit data. Continuously compare plans against actual enrollment to optimize supply predictions, minimizing shortages and waste.
Easily maintain clinically relevant parameters, support diverse study types, and seamlessly integrate with any IRT system. Streamline digital approval workflows before and throughout clinical trials.
Centralize product serial numbers and seamlessly meet country-specific serialization and reporting mandates with built-in regulatory compliance support.
Capture and store high volumes of objects, events, and business transactions, enabling on-demand reporting for deeper analysis and informed decision-making.
Integrate seamlessly with ERP, WMS, and packaging lines using the Warehouse Integration Toolkit to streamline logistics and enable end-to-end operational efficiency.
Track and manage serial numbers, sequential or randomized and their aggregations across the supply chain for complete traceability.
Seamlessly integrate master and transactional data with ERP and warehouse systems while capturing serialized trade item events directly from packaging lines for accurate tracking.
Drills into batch genealogy, deviation logs, inspection lots, and regional approvals, delivering clarity and context for QPs.
Monitors supply chain compliance, artwork alignment, country-specific registrations, and upstream release requirements for end-to-end control.

With every transaction, the system learns patterns, fine-tunes thresholds, and reduces false alerts enhancing reliability over time.
With our tailored compliance monitoring services and system, you’re equipped to raise compliance standards and strengthen your competitive advantage.

Resolve high-frequency errors like master data mismatches and transactional sync failures using built-in automation, reducing manual bottlenecks.
Orchestrate corrective actions across platforms while leveraging communication mining to surface unresolved threads and coordinate responses efficiently.
Set process checkpoints with smart triggers that adjust thresholds automatically ensuring proactive alerts before compliance gaps widen.
Powered by GS1-trained AI, the system identifies and explains exceptions in real time, delivering contextual recommendations to drive faster resolution.
Monitor serialization data across SAP ERP, WMS, ATTP, Middleware, and ICH within a centralized dashboard,enabling holistic oversight and faster decision-making.
Coordinate globally, act locally. Enable seamless cell orchestration across regions, partners, and regulatory zones with a unified platform that supports real-time decision-making and agile response to disruptions.
Meet evolving global regulatory requirements with confidence. SAP CGTO provides audit-ready documentation, version control, and end-to-end trace logs, supporting transparency, governance, and faster regulatory approvals.
Ensure patient safety is embedded, not just monitored. Automated checks, exception alerts, and verified handoffs reduce human error and uphold therapy integrity in high-stakes, time-sensitive delivery environments.
Move beyond dated and fragmented processes that increase manual errors. SAP CGTO intelligently orchestrates cross-functional workflows, ensuring real-time coordination across systems, sites, and stakeholders, reducing cycle times and operational risk.
Gain granular visibility across the entire therapy lifecycle, from collection to administration, all while safeguarding Chain of Identity (COI) and Chain of Custody (COC) with built-in traceability that meets regulatory and clinical precision requirements.
Optimize complex cell and gene therapy supply chains with SAP CGTO for full end-to-end visibility and compliance. Maintain chain-of-identity (COI) and chain-of-custody (COC) integrity to minimize errors and maximize patient safety.
Ensure secure, compliant batch releases with real-time decision support through SAP BRH. Empower Qualified Persons with structured automation that accelerates release cycles while maintaining regulatory adherence.
Protect product authenticity throughout the supply chain with SAP CORS. Gain complete traceability and transparency to meet stringent compliance and consumer safety standards, critical for effective digital supply chain solutions in regulated industries.
Enhance clinical trial supply efficiency with SAP ICSM’s real-time visibility and dynamic orchestration. Reduce waste, streamline stakeholder collaboration, and leverage intelligent forecasting to control costs and improve trial outcomes in life sciences.
Facilitate seamless, secure data sharing across your extended supply network. SAP ICH provides unmatched visibility and collaboration capabilities, helping you maintain compliance while optimizing digital supply chain management through effortless partner integration.
Deliver comprehensive end-to-end product traceability while ensuring strict global regulatory compliance. SAP ATTP safeguards pharmaceutical supply chains by preventing counterfeit drugs, protecting brand integrity, and enhancing supply chain integrity with real-time visibility.
We focus on applying AI Decision-making Tools to address specific pain points in industries such as healthcare, insurance, telecom, and customer service, enabling your business to operate with greater speed, accuracy, and intelligence.
We design scalable solutions using open frameworks and leading AI platforms, ensuring seamless integration with your existing technology for enhanced performance and scalability.
Move beyond traditional tools like chatbots and Automated Business Solutions to implement intelligent agents capable of advanced reasoning, decision-making, and task execution, unlocking new levels of productivity and insight.

Orchestrating transformation with confidence.
We help enterprises manage the human and operational aspects of transformation – ensuring seamless stakeholder alignment, training, governance, and adoption. Our structured approach enables resilient change and measurable business value.

Reliable, scalable, and intelligent managed support.
Our managed services ensure the ongoing performance and optimization of your SAP environments, AI workflows, and automation platforms. With 24/7 global support and proactive monitoring, we reduce operational overhead and drive continuous improvement.

Accelerate business transformation while delivering business value at every step Whether it’s SAP Supply Chain Transformation, AI/ML integration, or intelligent automation deployments, we manage the end-to-end complexities of enterprise-scale implementation with agility and precision – delivering scalable, secure, and compliant solutions.

Strategic guidance rooted deep in industry knowledge.
We help organizations define their digital transformation roadmap by aligning AI, automation, and SAP strategies with core business goals. From technology assessments to data-driven operating models, our advisory services lay the foundation for long-term success.

Build AI agents that adapt, reason, and deliver. Novatio’s AI business solutions automate end-to-end processes across dynamic enterprise environments. As an expert AI services provider, we enable scalable, intelligent automation for companies looking to unlock deeper efficiency and agility.
Go beyond automation and into creation. Our AI services leverage advanced foundation models to generate content, summarize data, and transform workflows making us one of the few AI development companies focused on real outcomes, not just experiments to initiate innovation.

Deliver smarter support and intuitive customer experiences with AI-powered chatbots, voice assistants, and agent assist tools. As a leading AI services company, Novatio builds AI solutions for business that reduce support costs, boost satisfaction, and streamline user engagement at scale.